Skip to Main Content
Exit Notice
You are about to leave ClinicalTrials.gov and go to:
URL:
http://download.veritasmedicine.com/PDF/CR003124_CSR.pdf
Label:
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of Infliximab (REMICADE®) Induction Therapy in Patients with Plaque-type Psoriasis.
Click on the link to continue.